Clinical response to unintended infusion of doxorubicin and vincristine over one instead of four days

Citation
Ja. Waddell et Ta. Coleman, Clinical response to unintended infusion of doxorubicin and vincristine over one instead of four days, AM J HEAL S, 57(13), 2000, pp. 1242-1244
Citations number
12
Categorie Soggetti
Pharmacology,"Pharmacology & Toxicology
Journal title
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
ISSN journal
10792082 → ACNP
Volume
57
Issue
13
Year of publication
2000
Pages
1242 - 1244
Database
ISI
SICI code
1079-2082(20000701)57:13<1242:CRTUIO>2.0.ZU;2-O
Abstract
Straightforward reports of unusual drug experiences are included in this se ction. While selected references may be cited, the purpose of a Drug Experi ence report is not to present an extensive review of the literature. A related section, Grand Rounds, includes papers that are well-documented p atient case reports with a thorough review of the important literature to h elp put the case in perspective. Authors should report serious adverse drug reactions to the FDA medical pro ducts reporting program (MedWatch). Such reporting will not jeopardize the chances that AJHP will publish manuscripts on the same drug reactions.